Patent AnalyticsExaminers
Rankings

Company or institution

VERTEX PHARMACEUTICALS INCORPORATED

1,152 applicationsfiled 2006 to 2026

Allowance rate
72%
−4 pts vs the USPTO range 69% to 74%
Rejections before allowance
1.4
−0.2 vs the USPTO
Months to first action
11.9 mo
−6.7 vs the USPTO
Needed an RCE
27%
level with the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

C07D Heterocyclic compounds596 apps
A61K Medical preparations339 apps
C12N Microorganisms or enzymes57 apps
C07K Peptides34 apps
A61P Therapeutic activity of compounds31 apps
C07C 24 apps

Art units

1625195 apps
1624175 apps
1626152 apps
162275 apps
162865 apps
162158 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19623181PHARMACEUTICAL COMPOSITIONS OF ALPHA-1 ANTITRYPSIN MODULATORS2026-09-11Pending00n/a
19586998POLYNUCLEOTIDES ENCODING CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR FOR TH…2026-05-13Pending00n/a
19583085COMPOUNDS FOR THE TREATMENT OF KIDNEY DISEASE2026-04-29Pending00n/a
15200064Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15805565Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15175406Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15969854Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15120131Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15788040Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15528311Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 1,152 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in